Elevation of Preprocedural Systemic Immune Inflammation Level Increases the Risk of Contrast-Associated Acute Kidney Injury Following Coronary Angiography: A Multicenter Cohort Study

Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has bee...

Full description

Saved in:
Bibliographic Details
Published inJournal of inflammation research Vol. 15; pp. 2959 - 2969
Main Authors Lai, Wenguang, Zhao, Xiaoli, Huang, Zhidong, Xie, Yun, Yu, Sijia, Tu, Jiabin, Guo, Dachuan, Xiu, Jiaming, Mai, Ziling, Li, Qiang, Huang, Haozhang, Li, Huanqiang, Xu, Jun-Yan, Lu, Hongyu, Chen, Guanzhong, Chen, Shiqun, Liu, Jin, Liu, Yong
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 31.05.2022
Dove
Dove Medical Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG). From January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count × neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 ≤404.5, Q2 >404.5 and ≤631.7, Q3 >631.7 and ≤1082.8, Q4 >1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI. A total of the 46,333 patients (62.9 ± 11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87-1.11, P = 0.771; Q3 group: OR: 1.04, 95% CI: 0.92-1.18, P = 0.553; Q4: OR: 1.65, 95% CI: 1.45-1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan-Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001). Elevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI.
AbstractList Background: Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG). Patients and Methods: From January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count X neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 [less than or equal to]404.5, Q2 >404.5 and [less than or equal to]631.7, Q3 >631.7 and [less than or equal to]1082.8, Q4 >1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI. Results: A total of the 46,333 patients (62.9 [+ or-]11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87-1.11,P = 0.771;Q3 group: OR: 1.04, 95% CI: 0.92-1.18,P = 0.553;Q4: OR: 1.65, 95% CI: 1.45-1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan-Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001). Conclusion: Elevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI. Keywords: systemic immune inflammation index, contrast-associated acute kidney injury, coronary angiography, preprocedural
Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG). From January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count × neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 ≤404.5, Q2 >404.5 and ≤631.7, Q3 >631.7 and ≤1082.8, Q4 >1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI. A total of the 46,333 patients (62.9 ± 11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87-1.11, P = 0.771; Q3 group: OR: 1.04, 95% CI: 0.92-1.18, P = 0.553; Q4: OR: 1.65, 95% CI: 1.45-1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan-Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001). Elevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI.
BackgroundInflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG). Patients and MethodsFrom January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count × neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 ≤404.5, Q2 >404.5 and ≤631.7, Q3 >631.7 and ≤1082.8, Q4 >1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI. ResultsA total of the 46,333 patients (62.9 ± 11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87-1.11, P = 0.771; Q3 group: OR: 1.04, 95% CI: 0.92-1.18, P = 0.553; Q4: OR: 1.65, 95% CI: 1.45-1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan-Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001). ConclusionElevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI.
Wenguang Lai,1,2,* Xiaoli Zhao,3,* Zhidong Huang,1,* Yun Xie,1,2,* Sijia Yu,1,4 Jiabin Tu,5 Dachuan Guo,6 Jiaming Xiu,5 Ziling Mai,1,2 Qiang Li,1 Haozhang Huang,1,4 Huanqiang Li,1 Jun-Yan Xu,1,7 Hongyu Lu,1 Guanzhong Chen,1 Shiqun Chen,1 Jin Liu,1 Yong Liu1 1Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People’s Republic of China; 2School of Biology and Biological Engineering, South China University of Technology, Guangzhou, People’s Republic of China; 3Department of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China; 4The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People’s Republic of China; 5Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, People’s Republic of China; 6Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China; 7Ministry of Education, Key Laboratory of Hainan Trauma and Disaster Rescue, College of Emergency and Trauma, Hainan Medical University, Haikou, 571199, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yong Liu; Jin Liu, Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People’s Republic of China, Email liuyong@gdph.org.cn; ljaw397017568@163.comBackground: Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG).Patients and Methods: From January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count × neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 ≤ 404.5, Q2 > 404.5 and ≤ 631.7, Q3 > 631.7 and ≤ 1082.8, Q4 > 1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI.Results: A total of the 46,333 patients (62.9 ± 11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87– 1.11, P = 0.771; Q3 group: OR: 1.04, 95% CI: 0.92– 1.18, P = 0.553; Q4: OR: 1.65, 95% CI: 1.45– 1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan–Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001).Conclusion: Elevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI.Keywords: systemic immune inflammation index, contrast-associated acute kidney injury, coronary angiography, preprocedural
Audience Academic
Author Xie, Yun
Xiu, Jiaming
Xu, Jun-Yan
Lu, Hongyu
Chen, Shiqun
Liu, Jin
Tu, Jiabin
Li, Qiang
Li, Huanqiang
Huang, Zhidong
Chen, Guanzhong
Guo, Dachuan
Mai, Ziling
Huang, Haozhang
Lai, Wenguang
Yu, Sijia
Zhao, Xiaoli
Liu, Yong
Author_xml – sequence: 1
  givenname: Wenguang
  surname: Lai
  fullname: Lai, Wenguang
  organization: School of Biology and Biological Engineering, South China University of Technology, Guangzhou, People's Republic of China
– sequence: 2
  givenname: Xiaoli
  surname: Zhao
  fullname: Zhao, Xiaoli
  organization: Department of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China
– sequence: 3
  givenname: Zhidong
  orcidid: 0000-0002-5267-5769
  surname: Huang
  fullname: Huang, Zhidong
  organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China
– sequence: 4
  givenname: Yun
  surname: Xie
  fullname: Xie, Yun
  organization: School of Biology and Biological Engineering, South China University of Technology, Guangzhou, People's Republic of China
– sequence: 5
  givenname: Sijia
  surname: Yu
  fullname: Yu, Sijia
  organization: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People's Republic of China
– sequence: 6
  givenname: Jiabin
  surname: Tu
  fullname: Tu, Jiabin
  organization: Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, People's Republic of China
– sequence: 7
  givenname: Dachuan
  surname: Guo
  fullname: Guo, Dachuan
  organization: Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China
– sequence: 8
  givenname: Jiaming
  surname: Xiu
  fullname: Xiu, Jiaming
  organization: Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, People's Republic of China
– sequence: 9
  givenname: Ziling
  surname: Mai
  fullname: Mai, Ziling
  organization: School of Biology and Biological Engineering, South China University of Technology, Guangzhou, People's Republic of China
– sequence: 10
  givenname: Qiang
  surname: Li
  fullname: Li, Qiang
  organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China
– sequence: 11
  givenname: Haozhang
  surname: Huang
  fullname: Huang, Haozhang
  organization: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People's Republic of China
– sequence: 12
  givenname: Huanqiang
  surname: Li
  fullname: Li, Huanqiang
  organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China
– sequence: 13
  givenname: Jun-Yan
  surname: Xu
  fullname: Xu, Jun-Yan
  organization: Ministry of Education, Key Laboratory of Hainan Trauma and Disaster Rescue, College of Emergency and Trauma, Hainan Medical University, Haikou, 571199, People's Republic of China
– sequence: 14
  givenname: Hongyu
  surname: Lu
  fullname: Lu, Hongyu
  organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China
– sequence: 15
  givenname: Guanzhong
  surname: Chen
  fullname: Chen, Guanzhong
  organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China
– sequence: 16
  givenname: Shiqun
  surname: Chen
  fullname: Chen, Shiqun
  organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China
– sequence: 17
  givenname: Jin
  surname: Liu
  fullname: Liu, Jin
  organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China
– sequence: 18
  givenname: Yong
  surname: Liu
  fullname: Liu, Yong
  organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35602662$$D View this record in MEDLINE/PubMed
BookMark eNptklFv0zAQxyM0xMbYE-_IEhJCQi124sTJHpCiaoNCEWiFZ8txLq2LYxfbKeoX4_Ph0DKtEvaDrfPv_ro7_58mZ8YaSJLnBE9TQtnbj_O76TIraEXyR8kFIaycMJyRswf38-TK-w0eF8M0pU-S8ywvcFoU6UXy-0bDTgRlDbId-upg66yEdnBCo-XeB-iVRPO-Hwyguem06PsDvYAd6BiSDoQHj8Ia0J3yP0aZmTXBCR8mtfdWKhGgRbUcAqBPqjWwj2mbwe3RrdXa_lJmFTOcNSKGarNSduXEdr2_RjX6POigJJgALjJr6wJahqHdP0sed0J7uDqel8n325tvsw-TxZf381m9mEha4HwiCwmE0bzpoKEYizyTtAPAUBHaprJJmxRIUzGW0a7psk5KRltJM8pIJYs8zy6T-UG3tWLDt071sUhuheJ_A9atuHCxQg08j0NtshxYy0rKoCyzqpKyErhsK0YpjlrvDlrboemhHbuKUz4RPX0xas1XdscrQgpKRoHXRwFnfw7gA--Vl6C1MGAHz-OPlimp8rSM6MsDuhKxNGU6GxXliPOaYUZZmqWj4PQ_VNzt-O3RaJ2K8ZOEVw8S1iB0WHurh9ER_hR8cwCls9476O7bJJiPxuXRuPxo3Ei_eDiZe_afTbM_yNHsGA
CitedBy_id crossref_primary_10_2147_JIR_S425189
crossref_primary_10_2147_CIA_S455588
crossref_primary_10_1371_journal_pone_0292646
crossref_primary_10_1002_clc_24219
Cites_doi 10.1259/bjr.20130738
10.1016/j.lfs.2020.118379
10.1158/1078-0432.CCR-14-0442
10.2147/JIR.S334941
10.1016/j.hlc.2016.01.007
10.1080/00365513.2022.2034034
10.1016/j.ccl.2019.04.001
10.5527/wjn.v6.i3.86
10.1016/j.jacc.2016.05.099
10.7326/0003-4819-150-9-200905050-00006
10.1016/j.jcin.2014.06.023
10.1016/j.jcin.2020.04.051
10.1161/CIRCULATIONAHA.112.103317
10.1038/nrneph.2014.180
10.1016/j.jacc.2004.06.068
10.1186/cc11228
10.1080/j.1600-0455.2003.00119.x
10.1007/s11239-020-02369-0
10.1111/eci.13230
10.3748/wjg.v23.i34.6261
10.1007/s40620-021-01021-1
10.1056/NEJMra1805256
10.1016/j.ebiom.2017.02.009
10.1016/j.ijcard.2015.04.242
10.1007/s11135-006-9018-6
10.1016/j.ijcard.2016.11.019
10.7150/jca.25691
10.1093/ndt/gfr807
10.1001/archinternmed.2011.1202
10.5301/jn.5000007
10.1080/14017431.2020.1846774
ContentType Journal Article
Copyright 2022 Lai et al.
COPYRIGHT 2022 Dove Medical Press Limited
2022 Lai et al. 2022 Lai et al.
Copyright_xml – notice: 2022 Lai et al.
– notice: COPYRIGHT 2022 Dove Medical Press Limited
– notice: 2022 Lai et al. 2022 Lai et al.
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.2147/JIR.S364915
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList

PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Lai et al
EISSN 1178-7031
EndPage 2969
ExternalDocumentID oai_doaj_org_article_5356b35e7d7847e88399cc9a08d97440
A707472320
10_2147_JIR_S364915
35602662
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: ;
GroupedDBID ---
0YH
29K
2WC
53G
5VS
7RV
8FE
8FH
8FI
8FJ
8G5
ABUWG
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BKEYQ
BPHCQ
BVXVI
CCPQU
D-I
DIK
DWQXO
E3Z
EBD
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
LK8
M2O
M48
M7P
M~E
NAPCQ
NPM
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TR2
UKHRP
VDV
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c4605-c6ce1745bfeb400a53c4fee0e914d2cb2b2e1b97734fbf3fcc74dc434719c6553
IEDL.DBID RPM
ISSN 1178-7031
IngestDate Tue Oct 22 15:15:16 EDT 2024
Tue Sep 17 21:24:33 EDT 2024
Fri Aug 16 11:47:28 EDT 2024
Thu Feb 22 23:46:20 EST 2024
Tue Nov 12 23:20:44 EST 2024
Tue Aug 20 22:14:19 EDT 2024
Thu Sep 26 16:37:43 EDT 2024
Sat Sep 28 08:18:26 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords contrast-associated acute kidney injury
preprocedural
systemic immune inflammation index
coronary angiography
Language English
License 2022 Lai et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4605-c6ce1745bfeb400a53c4fee0e914d2cb2b2e1b97734fbf3fcc74dc434719c6553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work
ORCID 0000-0002-5267-5769
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116410/
PMID 35602662
PQID 2668219528
PQPubID 23479
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_5356b35e7d7847e88399cc9a08d97440
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9116410
proquest_miscellaneous_2668219528
gale_infotracmisc_A707472320
gale_infotracacademiconefile_A707472320
gale_healthsolutions_A707472320
crossref_primary_10_2147_JIR_S364915
pubmed_primary_35602662
PublicationCentury 2000
PublicationDate 20220531
PublicationDateYYYYMMDD 2022-05-31
PublicationDate_xml – month: 05
  year: 2022
  text: 20220531
  day: 31
PublicationDecade 2020
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
PublicationTitle Journal of inflammation research
PublicationTitleAlternate J Inflamm Res
PublicationYear 2022
Publisher Dove Medical Press Limited
Dove
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Dove
– name: Dove Medical Press
References Jang (ref6) 2015; 11
Machado (ref29) 2012; 27
Liu (ref30) 2021; 52
Mehran (ref13) 2004; 44
Chen (ref19) 2017; 23
Yang (ref8) 2018; 9
Lu (ref28) 2017; 17
Toso (ref25) 2014; 7
Zheng (ref9) 2021; 14
Ozkok (ref32) 2017; 6
Fuernau (ref23) 2015; 191
Laskey (ref27) 2003; 44
Liu (ref5) 2012; 25
Yang (ref10) 2020; 50
Kwasa (ref17) 2014; 87
Quintavalle (ref26) 2012; 126
Zhang (ref24) 2020; 259
Gok (ref20) 2021; 55
Esenboğa (ref21) 2022; 82
Mehran (ref16) 2019; 380
Hu (ref7) 2014; 20
O’Brien (ref15) 2007; 41
Amin (ref2) 2012; 172
Briguori (ref11) 2020; 13
Sato (ref3) 2017; 227
McCullough (ref4) 2016; 68
Kinsey (ref31) 2012; 16
Lun (ref1) 2021; 34
Kumar (ref22) 2019; 37
Kurtul (ref14) 2016; 25
Levey (ref12) 2009; 150
Tanık (ref18) 2019; 14
References_xml – volume: 87
  start-page: 20130738
  year: 2014
  ident: ref17
  publication-title: Br J Radiol
  doi: 10.1259/bjr.20130738
  contributor:
    fullname: Kwasa
– volume: 14
  start-page: 59
  year: 2019
  ident: ref18
  publication-title: J Tehran Heart Cent
  contributor:
    fullname: Tanık
– volume: 259
  start-page: 118379
  year: 2020
  ident: ref24
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2020.118379
  contributor:
    fullname: Zhang
– volume: 20
  start-page: 6212
  year: 2014
  ident: ref7
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-0442
  contributor:
    fullname: Hu
– volume: 14
  start-page: 5769
  year: 2021
  ident: ref9
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S334941
  contributor:
    fullname: Zheng
– volume: 25
  start-page: 683
  year: 2016
  ident: ref14
  publication-title: Heart Lung Circ
  doi: 10.1016/j.hlc.2016.01.007
  contributor:
    fullname: Kurtul
– volume: 82
  start-page: 132
  year: 2022
  ident: ref21
  publication-title: Scand J Clin Lab Invest
  doi: 10.1080/00365513.2022.2034034
  contributor:
    fullname: Esenboğa
– volume: 37
  start-page: 251
  year: 2019
  ident: ref22
  publication-title: Cardiol Clin
  doi: 10.1016/j.ccl.2019.04.001
  contributor:
    fullname: Kumar
– volume: 6
  start-page: 86
  year: 2017
  ident: ref32
  publication-title: World J Nephrol
  doi: 10.5527/wjn.v6.i3.86
  contributor:
    fullname: Ozkok
– volume: 68
  start-page: 1465
  year: 2016
  ident: ref4
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2016.05.099
  contributor:
    fullname: McCullough
– volume: 150
  start-page: 604
  year: 2009
  ident: ref12
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-150-9-200905050-00006
  contributor:
    fullname: Levey
– volume: 7
  start-page: 1421
  year: 2014
  ident: ref25
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2014.06.023
  contributor:
    fullname: Toso
– volume: 13
  start-page: 2065
  year: 2020
  ident: ref11
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2020.04.051
  contributor:
    fullname: Briguori
– volume: 126
  start-page: 3008
  year: 2012
  ident: ref26
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.112.103317
  contributor:
    fullname: Quintavalle
– volume: 11
  start-page: 88
  year: 2015
  ident: ref6
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2014.180
  contributor:
    fullname: Jang
– volume: 44
  start-page: 1393
  year: 2004
  ident: ref13
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2004.06.068
  contributor:
    fullname: Mehran
– volume: 16
  start-page: 214
  year: 2012
  ident: ref31
  publication-title: Crit Care
  doi: 10.1186/cc11228
  contributor:
    fullname: Kinsey
– volume: 44
  start-page: 498
  year: 2003
  ident: ref27
  publication-title: Acta Radiol
  doi: 10.1080/j.1600-0455.2003.00119.x
  contributor:
    fullname: Laskey
– volume: 52
  start-page: 440
  year: 2021
  ident: ref30
  publication-title: J Thromb Thrombolysis
  doi: 10.1007/s11239-020-02369-0
  contributor:
    fullname: Liu
– volume: 50
  start-page: e13230
  year: 2020
  ident: ref10
  publication-title: Eur J Clin Invest
  doi: 10.1111/eci.13230
  contributor:
    fullname: Yang
– volume: 23
  start-page: 6261
  year: 2017
  ident: ref19
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v23.i34.6261
  contributor:
    fullname: Chen
– volume: 34
  start-page: 1479
  year: 2021
  ident: ref1
  publication-title: J Nephrol
  doi: 10.1007/s40620-021-01021-1
  contributor:
    fullname: Lun
– volume: 380
  start-page: 2146
  year: 2019
  ident: ref16
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1805256
  contributor:
    fullname: Mehran
– volume: 17
  start-page: 101
  year: 2017
  ident: ref28
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2017.02.009
  contributor:
    fullname: Lu
– volume: 191
  start-page: 159
  year: 2015
  ident: ref23
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2015.04.242
  contributor:
    fullname: Fuernau
– volume: 41
  start-page: 673
  year: 2007
  ident: ref15
  publication-title: Qual Quant
  doi: 10.1007/s11135-006-9018-6
  contributor:
    fullname: O’Brien
– volume: 227
  start-page: 424
  year: 2017
  ident: ref3
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2016.11.019
  contributor:
    fullname: Sato
– volume: 9
  start-page: 3295
  year: 2018
  ident: ref8
  publication-title: J Cancer
  doi: 10.7150/jca.25691
  contributor:
    fullname: Yang
– volume: 27
  start-page: 3136
  year: 2012
  ident: ref29
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfr807
  contributor:
    fullname: Machado
– volume: 172
  start-page: 246
  year: 2012
  ident: ref2
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2011.1202
  contributor:
    fullname: Amin
– volume: 25
  start-page: 332
  year: 2012
  ident: ref5
  publication-title: J Nephrol
  doi: 10.5301/jn.5000007
  contributor:
    fullname: Liu
– volume: 55
  start-page: 91
  year: 2021
  ident: ref20
  publication-title: Scand Cardiovasc J
  doi: 10.1080/14017431.2020.1846774
  contributor:
    fullname: Gok
SSID ssj0000070424
Score 2.3163617
Snippet Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune...
Background: Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic...
BackgroundInflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic...
Wenguang Lai,1,2,* Xiaoli Zhao,3,* Zhidong Huang,1,* Yun Xie,1,2,* Sijia Yu,1,4 Jiabin Tu,5 Dachuan Guo,6 Jiaming Xiu,5 Ziling Mai,1,2 Qiang Li,1 Haozhang...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2959
SubjectTerms Angiography
Cardiac patients
contrast-associated acute kidney injury
coronary angiography
Immune response
Inflammation
Original Research
preprocedural
Risk factors
systemic immune inflammation index
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojyXFjBSJU6h2diOY24L6qpbHkKFSr1FsT1uAyiLNrtC_WP8Pmbi7CoRBy5c40kUeybzjeOZbxg7EoV1ynuF2xJjE6lTlZgUssRI4SzCvUhtlyD7KT-9kGeX6nLQ6otywiI9cFy4YyVUboUC7TU6UigQ0I1zpkoLb4jcrvO-qRlspmLgq-lML3ZWKRIiaY_FedSW5_hscf76i8iloWa4AzjqWPv_9s0DcBonTg6QaH6P3e1DSD6Lr77PbkFzn93-2B-SP2C_T35A_NHKl4F_JtpKBClP_Bo8EpTXji-oLgT4ogloErF8kX-gBCK8RIFkCy3H2JCf1-13egyxWK2qdp1s9Qmez9xmDfx97Ru4wdu-oXr4HO1q-QvxEO9YLanWl8-aq7onxn7DZ7wr-aWpwQplrjH855TMePOQXcxPvr47Tfr2DImjw9TE5Q5wP6NsAIueoFLCyQCQgplKn6GmbQZTi_GlkMEGEZzT0jspEA6Ny5USj9hes2zgCeNT7Z0GH1IogtSVscJnmQ6QZUGnlQgTdrTVUvkzsnCUuHshZZaozLJX5oS9JQ3uRIg6u7uABlX2BlX-y6Am7AXpv4x1qDsHUM409RrAABQlXnUS5AJw6V3VVzLgXIhMayR5OJLET9eNhl9ubaykIcp3a2C5aUsMmwrEEpUVE_Y42txuVvj-uHHOswnTI2scTXs80tTXHXM4Ilsup-nT_7FOB-xORqUgXSbFIdtbrzbwDAO0tX3efYt_AKnDORE
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIlW9IN4sFDBSJU4pWT_iBAmhBXXVlodQYaXeotgetwtVAsmuYP8Yv4-ZJLtqgBPXeBzJ-caemXjmG8b2ZWqd9l5jWJLZSJlYR1kMIsqUdBbNvYxtmyD7ITmaqZMzfbbF1s04-w_Y_DO0o35Ss_ry4Of31Svc8C8pjXmszPOT49ODTzJRGRWbXxMKQ3TK4ev9_M4PNnTF19Xn_Tlnl-1ITZ2YEjEwTi2H_98n9RVTNUyjvGKXpjfY9d6h5JNOA26yLShvsZ33_ZX5bfbr8BK63668CvwjkViiyfLEtsE7uvK548dUJQL8uAyoIF0xI39H6UT4iNzKBhqOniI_nTdf6TXEaVUXzSJaowueT9xyAfzt3JewwmlfECw-RS2rfqB1xBl1RZW_fFKez3ua7Bd8wtsCYFoa1ChzgThwSm1c3WGz6eHnN0dR36whcnS1GrnEAUY32gaweC4UWjoVAGLIxsoLxN0KGFv0NqUKNsjgnFHeKYnGMXOJ1vIu2y6rEu4zPjbeGfAhhjQoU2RWeiFMACGCiQsZRmx_jVL-rePkyDGWIVxzxDXvcR2x14TgRoSItNsHVX2e9_sy1wi9lRqMN2inIUV_MXMuK-LUZ8SdOGJPCP-8q0rdHAf5xFDnAXRHUeJZK0Eqip_eFX1dA66FqLUGknsDSdzIbjD8dK1jOQ1R9lsJ1bLJUTVTtCxapCN2r9O5zarWqjtiZqCNg2UPR8r5RcsjjnYuUeP4wX_PfMh2BVWDtMkUe2x7US_hEfpoC_u43X-_AcQRPxo
  priority: 102
  providerName: Scholars Portal
Title Elevation of Preprocedural Systemic Immune Inflammation Level Increases the Risk of Contrast-Associated Acute Kidney Injury Following Coronary Angiography: A Multicenter Cohort Study
URI https://www.ncbi.nlm.nih.gov/pubmed/35602662
https://search.proquest.com/docview/2668219528
https://pubmed.ncbi.nlm.nih.gov/PMC9116410
https://doaj.org/article/5356b35e7d7847e88399cc9a08d97440
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61RUJcEO8GSlikSpyc2N5dr80trRKaQqooUKk3y_tqDa1d5SHUP8bvY8aPKBY3Lj54Z6OsvxnPrHfmG0KOWay0MEbAtiRRHpe-8BLfhl7CmVbg7pmvqgTZi-jskp9fias9ItpamCppX6t8UNzeDYr8psqtvL_TwzZPbDifnYKBRjzwh_tkHxR0Z4tex7wSj_PqWjzswjM8ny4G31nEkwD71DCBXZeisOOIKr7-f9_KO26pmzK544Mmz8jTJniko_pPPid7tnhBHs-a4_GX5M_41tafWGnp6BwJK8E9GWTWoDU1ea7pFCtCLJ0WDpShLlyk3zB1CG5hCLmyKwpRIV3kq1_4M8hftcxWa69F0ho60pu1pV9zU9gHmPYTgKET0KjyN3hCmLEsscqXjorrvKHE_kxHtCr2xaXZJcjcQOBPMY3x4RW5nIx_nJ55TWMGT-MxqqcjbWEnI5SzCt4BmWCaO2t9mwTchICxCm2gILJk3CnHnNaSG80ZOMJER0Kw1-SgKAt7SGggjZbWON_GjsssUcyEoXQ2DJ30M-Z65LhFKb2v-TdS2Lcgringmja49sgJIrgVQdLs6ka5vE4b1UkFQK-YsNJI8Mk2htgw0TrJ_NgkyJPYIx8Q_7SuQN2afjqS2GUAQk-Q-FRJoPHDo9dZU8MAa0EarY7kUUcSjFZ3hj-2OpbiEGa6FbbcrFJQzRi8iAjjHnlT69x2Va3q9ojsaGNn2d0RMKGKM7wxmbf_PfMdeRJi5UeVOHFEDtbLjX0P8dha9cmjk_HFfNGvvmfA9ctVANcZj_uVZf4FdNo9EA
link.rule.ids 230,315,730,783,787,867,888,2109,24330,27936,27937,33757,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL4s1CoUaqxCm72diOE25L1dVuu1tVpZV6s-JXG2iTah9C_WP8PmbyWG3EjWs8juJ8M5lxPPMNIQcs0UZYK2BbkuqAy1AEaeiiIOXMaHD3LNRVguxpPLnkx1fiaoeIthamSto3Ou8Xt3f9Ir-pcivv78ygzRMbnM0PwUBjPgwHj8hjsNeQb23S66hX4oFeXY2HfXgGx9Pz_g8W83SInWqYwL5LcdRxRRVj_7_f5S3H1E2a3PJC4xfkeRM-0lH9mC_JjitekSfz5oD8NflzdOvqn6y09PQMKSvBQVnk1qA1OXlu6BRrQhydFh7UoS5dpDNMHoJLGEQu3ZJCXEjP8-UvvA0yWC2y5SposXSWjsx65ehJbgv3ANN-AjR0DDpV_gZfCDMWJdb50lFxnTek2N_oiFblvrg0twCZGwj9KSYyPrwhl-Oji8NJ0LRmCAwepAYmNg72MkJ7p-ErkAlmuHcudOmQ2whQ1pEbaogtGffaM2-M5NZwBq4wNbEQ7C3ZLcrCvSd0KK2RzvrQJZ7LLNXMRpH0Loq8DDPme-SgRUnd1wwcCnYuiKsCXFWDa498RwQ3IkibXV0oF9eqUR4lAHrNhJNWgld2CUSHqTFpFiY2RabEHtlH_FVdg7oxfjWS2GcAgk-Q-FpJoPnDqzdZU8UAa0EirY7kXkcSzNZ0hr-0OqZwCHPdCleulwpUMwE_IqKkR97VOrdZVau6PSI72thZdncEjKhiDW-M5sN_z9wnTycX85maTU9PPpJnEdaBVGkUe2R3tVi7TxCdrfTnyhb_AgGNPAw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBa2Dih2GfZutm7VgAI7uXEsybJ3y7oGTV8IuhXozbAkqvXW2kEeGPrH9vtG2k4QY7ddLcqw8pEiFZEfGdsXibHKOYXHktQEUocqSEOIglQKa9Ddi9DUCbIX8fGVPLlW1xutvuqkfWuKg_Lu_qAsbuvcyum97a_yxPqT80M00FgOwv7U-f5j9gRtNow3DupN5KvpUq-pyKNePP2T8eXBdxHLdEDdaoSi3ktx1HFHNWv_v3vzhnPqJk5ueKLRc_asDSH5sPnUF-wRlC_Z9nl7Sf6K_Tm6g-aPVl55PiHaSnRSjvg1eENQXlg-proQ4OPSo0o05Yv8jBKI8BEFknOYc4wN-WUx_0WvIRarWT5fBCs8wfGhXS6AnxauhAec9hPh4SPUq-o3-kOcMauo1pcPy5uiJcb-woe8LvmlpcEMZW4x_OeUzPjwml2Njn4cHgdte4bA0mVqYGMLeJ5RxoPBnSBXwkoPEEI6kC5CpE0EA4PxpZDeeOGt1dJZKdAdpjZWSrxhW2VVwg7jA-2sBudDSLzUeWqEiyLtIYq8DnPhe2x_hVI2bVg4Mjy9EK4Z4pq1uPbYV0JwLULU2fWDanaTtQqUKYTeCAXaafTMkGCEmFqb5mHiUmJL7LE9wj9r6lDXG0A21NRrAANQlPhcS9AWgD-9zdtKBlwLkWl1JHc7kmi6tjP8aaVjGQ1RvlsJ1XKeoWom6EtUlPTY20bn1qtaqW6P6Y42dpbdHUFDqpnDW8N5998z99j25NsoOxtfnL5nTyMqBakzKXbZ1mK2hA8YoC3Mx9oU_wJlqz0f
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevation+of+Preprocedural+Systemic+Immune+Inflammation+Level+Increases+the+Risk+of+Contrast-Associated+Acute+Kidney+Injury+Following+Coronary+Angiography%3A+A+Multicenter+Cohort+Study&rft.jtitle=Journal+of+inflammation+research&rft.au=Lai%2C+Wenguang&rft.au=Zhao%2C+Xiaoli&rft.au=Huang%2C+Zhidong&rft.au=Xie%2C+Yun&rft.date=2022-05-31&rft.pub=Dove&rft.eissn=1178-7031&rft.volume=15&rft.spage=2959&rft.epage=2969&rft_id=info:doi/10.2147%2FJIR.S364915&rft_id=info%3Apmid%2F35602662&rft.externalDBID=PMC9116410
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-7031&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-7031&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-7031&client=summon